Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain
- 29 April 2005
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 330 (1), 39-45
- https://doi.org/10.1016/j.bbrc.2005.02.117
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Generation of Synthetic Severe Acute Respiratory Syndrome Coronavirus Pseudoparticles: Implications for Assembly and Vaccine ProductionJournal of Virology, 2004
- Crystal Structure of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Fusion CoreJournal of Biological Chemistry, 2004
- Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptidesProceedings of the National Academy of Sciences of the United States of America, 2004
- Structural Characterization of the SARS-Coronavirus Spike S Fusion Protein CorePublished by Elsevier BV ,2004
- Crystallization and preliminary X-ray diffraction analysis of post-fusion six-helix bundle core structure from Newcastle disease virus F protein.Acta Crystallographica Section D-Structural Biology, 2003
- A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong KongNew England Journal of Medicine, 2003
- Identification of Severe Acute Respiratory Syndrome in CanadaNew England Journal of Medicine, 2003
- Mechanisms of Viral Membrane Fusion and Its InhibitionAnnual Review of Biochemistry, 2001
- Membrane Fusion Mediated by Coiled Coils: A HypothesisBiophysical Journal, 2000
- Expression cloning of new receptors used by simian and human immunodeficiency virusesNature, 1997